|
(11) Diet Modification to Augment Radiation for Breast Cancer Brain Metastases
|
1R01CA227479-01
|
$351,726
|
|
SIMONE, NICOLE
|
THOMAS JEFFERSON UNIVERSITY
|
|
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
|
1R01CA227466-01
|
$699,062
|
|
ZIV, ELAD
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
|
1R01CA227505-01
|
$620,860
|
|
KIRCHHOFF, TOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
1R01CA227473-01
|
$580,767
|
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
|
5R01CA208526-03
|
$472,047
|
|
CUCINOTTA, FRANCIS
|
UNIVERSITY OF NEVADA LAS VEGAS
|
|
(PQ 12) Targeting SMPDL3b to Prevent Radiation-Induced Nephrotoxicity
|
1R01CA227493-01
|
$427,990
|
|
MARPLES, BRIAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ1) Epigenetic effects of the premalignant field
|
5R01CA208620-03
|
$415,599
|
|
TERADA, LANCE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
|
1R01CA219896-01A1
|
$429,943
|
|
WARGO, JENNIFER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes
|
1R21CA227232-01
|
$208,746
|
|
TURNBAUGH, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
|
1R01CA219871-01A1
|
$451,326
|
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ10) Understanding How Commensal Microbiota Affect the Anti-tumor Action of Radiotherapy
|
1R21CA227528-01
|
$176,175
|
|
WEICHSELBAUM, RALPH
|
UNIVERSITY OF CHICAGO
|
|
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
|
1R01CA219637-01A1
|
$281,441
|
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
|
1R01CA227237-01
|
$686,519
|
|
GUSEV, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-03
|
$518,165
|
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
|
5R01CA206477-03
|
$791,933
|
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Relevance of VDAC2 heterogeneity for hepatic tumor growth and targeting
|
1R01CA216254-01A1
|
$413,916
|
|
HAJNOCZKY, GYORGY
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ6) Roles of circadian rhythms in tumor development
|
1R21CA227379-01
|
$208,800
|
|
HONG, CHRISTIAN
|
UNIVERSITY OF CINCINNATI
|
|
(PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?
|
1R21CA227375-01
|
$224,199
|
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
|
5R01CA205101-03
|
$384,612
|
|
SKALA, MELISSA
|
MORGRIDGE INSTITUTE FOR RESEARCH, INC.
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-04
|
$969,219
|
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
|
5R01CA201250-03
|
$695,342
|
|
LARSON, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
5R01CA195686-03
|
$366,000
|
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-04
|
$789,845
|
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
2018 Lysosomes and Endocytosis Gordon Research Conference and Gordon Research Seminar
|
1R13CA228143-01
|
$3,000
|
|
WEISMAN, LOIS
|
GORDON RESEARCH CONFERENCES
|
|
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
|
2R01CA174844-04
|
$575,010
|
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-05
|
$765,486
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
|
5R01CA210625-02
|
$542,711
|
|
CARPENTER, MATTHEW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A network-based approach for personalized treatment of Multiple Myeloma
|
5R21CA209875-02
|
$184,331
|
|
PAREKH, SAMIR
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
3R01CA190776-04S1
|
$116,456
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-06
|
$368,984
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
|
1R01CA218008-01A1
|
$599,752
|
|
GREEN, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
A novel time-resolved fluorescence-based high-throughput screening technology for discovering allosteric kinase inhibitors
|
5R21CA217695-02
|
$231,000
|
|
LEVINSON, NICHOLAS
|
UNIVERSITY OF MINNESOTA
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
|
5R01CA200977-03
|
$639,777
|
|
GANZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A plasticity and reprogramming paradigm for therapy resistance at the single cell level
|
1U01CA227550-01
|
$598,501
|
|
RAJ, ARJUN
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles
|
5F30CA221250-02
|
$49,524
|
|
SCHNORENBERG, MATHEW
|
UNIVERSITY OF CHICAGO
|
|
A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning
|
5R01CA199137-04
|
$55,401
|
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
A Psychosocial Intervention to Improve Outcomes for Parents with Advanced Cancer
|
5K07CA218167-02
|
$176,839
|
|
PARK, ELIZA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
|
5R01CA207133-03
|
$554,387
|
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
A scalable image-based approach for profiling and annotating very large compound
|
5R01CA184984-05
|
$499,024
|
|
WU, LANI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Solid-State Nanopore miRNA Quantification Technology
|
5R21CA206904-03
|
$193,125
|
|
CHANG, HSUEH-CHIA
|
UNIVERSITY OF NOTRE DAME
|
|
A Training Program in Cancer Biology and Therapeutics (CBT)
|
5T32CA009054-39
|
$379,994
|
|
FRUMAN, DAVID
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Abbreviated MRI Breast Screening protocol
|
5F31CA217160-02
|
$32,943
|
|
JIMENEZ, JORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S6
|
$7,064,076
|
$141,282
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S7
|
$100,000
|
$2,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S8
|
$50,000
|
$1,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activating p53 for colorectal cancer prevention
|
1R01CA214954-01A1
|
$439,704
|
|
WU, XIANGWEI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Vascular Disease for this search: $13,355,567
|